Closed
Source verified August 11, 2026
Capital Access Advisory Program (CAAP) — Building Companies
Support for Ontario bioscience companies raising capital
Receipt of requests is now closed
Get notified about updates to this grant.
Latest source updateLast Update: August 11, 2026Latest change: The CAAP Building Companies page removed the application notice, program description, eligibility text, and contact details, and now mainly shows company alumni listings.View change
Latest source update
Last Update: August 11, 2026
Latest change: The CAAP Building Companies page removed the application notice, program description, eligibility text, and contact details, and now mainly shows company alumni listings.
CAAP page now shows alumni listings and removes application details
The Building Companies page no longer shows the “not currently accepting applications” notice, the program description, or the eligibility text that were previously visible. It also removed the contact name and email for the advisory program. The page now mainly presents CAAP Companies alumni sections, including a new CAAP Companies 2026 section and updated company listings across prior years.
Funding available
Varies by project
Deadline
Closed
Location
Ontario, Canada
Overview
OBIO’s CAAP® is a program for private, high-potential bioscience companies based in Ontario, designed to accelerate technology commercialization and support the path toward Series A financing and strategic partnerships. It focuses on business strategic planning, advanced fundraising strategies, and closing an investment round and business development contract.
Receipt of requests is now closed
Get notified about updates to this grant.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Strengthen organizational capacity
- Access new markets
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Ontario
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Technology commercialization for health science companies.
- Strategic planning for a post-seed financing round.
- Fundraising, financial modeling, and investment closing.
- Participation in the OBIO Investment Summit and other international investment conferences.
Official resources
Eligibility
Who is eligible?
- Private, high-potential bioscience companies based in Ontario.
- Companies focused on developing human health science products.
- Companies starting to raise a post-seed financing round in the next 12-18 months.
Eligible geographic areas
- Ontario
Selection criteria
- High growth potential.
- Readiness to raise post-seed financing.
- Alignment with health science commercialization goals.
- Management team engagement in the program.
How to apply
- Step 1: Complete the online intake form
- Access the application form provided by OBIO.
- Enter the required organization and contact details.
- Complete the form and submit it online.
- Step 2: Await review
- OBIO reviews submitted applications.
- Only selected companies are contacted for the next stage.
Processing and Agreement
- Applications are reviewed after submission.
- Only selected companies move to the next stage.
- No further decision details are provided.
Additional information
- OBIO’s CAAP® creates high value deal flow for both companies and investors.
- CAAP® culminates with a presentation at the OBIO® Investment Summit (OIS).
Contacts
Frequently Asked Questions about the Capital Access Advisory Program (CAAP) — Building Companies Program
What is the Capital Access Advisory Program (CAAP) — Building Companies?
OBIO’s CAAP® is a program for private, high-potential bioscience companies based in Ontario, designed to accelerate technology commercialization and support the path toward Series A financing and strategic partnerships. It focuses on business strategic planning, advanced fundraising strategies, and closing an investment round and business development contract.
Who is eligible for the Capital Access Advisory Program (CAAP) — Building Companies program?
To be eligible for the Capital Access Advisory Program (CAAP) — Building Companies program, you must:
Private, high-potential bioscience companies based in Ontario.
Companies developing human health science products.
Companies starting to raise a post-seed financing round in the next 12-18 months.
What expenses are eligible under Capital Access Advisory Program (CAAP) — Building Companies?
Technology commercialization for health science companies.
Strategic planning for a post-seed financing round.
Fundraising, financial modeling, and investment closing.
Participation in the OBIO Investment Summit and other international investment conferences.
Who can I contact for more information about the Capital Access Advisory Program (CAAP) — Building Companies?
You can contact Ontario Bioscience Innovation Organization (OBIO) by email at parniantajbakhsh@obio.ca.
Where is the Capital Access Advisory Program (CAAP) — Building Companies available?
The Capital Access Advisory Program (CAAP) — Building Companies program is available the province of Ontario.
Is the Capital Access Advisory Program (CAAP) — Building Companies a grant, loan, or tax credit?
Capital Access Advisory Program (CAAP) — Building Companies is a Partnering and Collaboration
Who are the financial supporters of the Capital Access Advisory Program (CAAP) — Building Companies?
Capital Access Advisory Program (CAAP) — Building Companies is funded by Ontario Bioscience Innovation Organization (OBIO)